SCHEMBL24099148

SCHEMBL24099148

Cn1ncc2c(=O)[nH]c3cc(F)ccc3c21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.48
KDM4E B2RXH2 2/20 0.44
FEN1 P39748 1/20 0.42
DAO P14920 2/20 0.41
CDC25A P30304 1/20 0.40
CDC25C P30307 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CDK2 P24941 3/20 0.38
CCNE2 O96020 2/20 0.38
CDK4 P11802 2/20 0.38
CCND1 P24385 2/20 0.38
CCNE1 P24864 2/20 0.38
DDO Q99489 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
PDGFRB P09619 1/20 0.38
FGFR1 P11362 1/20 0.38
KDR P35968 1/20 0.38
CCNB2 O95067 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30380737 1.00 PARP1 (0.48) PARP1KDM4EFEN1DAOCDC25A
SCHEMBL28999960 0.83 PTGES (0.45) CDK2CCNE2CDK4CCND1CCNE1
SCHEMBL30273162 0.83 PTGES (0.45) CDK2CCNE2CDK4CCND1CCNE1
SCHEMBL24121204 0.82 MPO (0.38) PARP1PDGFRBFGFR1KDR
SCHEMBL30380822 0.82 MPO (0.38) PARP1PDGFRBFGFR1KDR
SCHEMBL6783202 0.80 FEN1 (0.42) PARP1KDM4EFEN1DAOMEN1
SCHEMBL31552840 0.80 PARP1 (0.43) PARP1KDM4EKMT2AHPGDHTT
SCHEMBL30273156 0.80 PARP1 (0.50) PARP1KDM4EDAOCDK2LMNA
SCHEMBL31386900 0.80 PARP1 (0.55) PARP1KDM4EKMT2AHPGD
SCHEMBL29203527 0.80 PARP1 (0.41) PARP1LMNAHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116075512-A Heterocyclic compounds and imaging agents for imaging huntingtin CHDI基金会股份有限公司 2023-05-05 CN disclosed
US-20210393812-A1 HETEROCYCLIC COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2021-12-23 US disclosed
WO-2021252775-A1 HETEROCYCLIC COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210393812-A1 HETEROCYCLIC COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, HSPBP1 PARP1 3115/4885KDM4E 4698/4885FEN1 3894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.